Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 15,500 | |||
25 mg | 在庫あり | ¥ 33,000 | |||
50 mg | 在庫あり | ¥ 52,500 | |||
100 mg | 在庫あり | ¥ 84,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,000 |
説明 | JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2. |
ターゲット&IC50 | FAAH (rat):10 nM, FAAH (human):12 nM |
別名 | JNJ1661010, Takeda-25, JNJ 1661010 |
分子量 | 365.45 |
分子式 | C19H19N5OS |
CAS No. | 681136-29-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 3.7 mg/mL (10 mM)
DMSO: 36.6 mg/mL (100 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-1661010 681136-29-8 Metabolism Neuroscience FAAH broad-spectrum acid inhibit hydrolase barrier JNJ1661010 Takeda25 Fatty acid amide hydrolase amide Takeda 25 blood-brain Inhibitor analgesics Takeda-25 Fatty JNJ 1661010 inhibitor